NASDAQ$VTRS
Viatris Inc · Q3 2025 earnings
Q3 2025 earnings · · Before market open · Investor relations
Briefing
Viatris reported Q3 2025 total revenues of €3.76B with solid generics and established brands performance.
Total revenues were €3.76 billion. The company continues portfolio optimization, pipeline investments, and cost actions across North America, Europe, and emerging markets. FX and India manufacturing issues remain headwinds cited in the 10-Q.
- Q3 total revenues €3.76B.
- Generics and established brands anchor the revenue base.
- India supply and FDA actions weighed on prior guidance.
- Pipeline and capital allocation updates in MD&A.
Headline financials
Revenue & EPS history
Viatris · Revenue · Quarterly
$3.76B
Revenue by segment
Viatris · $2.44B total across 1 segment · Q2 2023
- Brands$2.44B-1.5%100.0%
Forward guidance
The filing discusses Viatris's outlook, including capital allocation, operating priorities, and market risks relevant to the reported quarter.
Tailwinds
- Viatris cites operational priorities and demand trends supporting the outlook.
- Balance sheet and liquidity actions aim to fund growth and returns.
Headwinds
- Macro, pricing, and input-cost volatility could pressure margins.
- Segment mix and one-time items may affect quarter-to-quarter comparability.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2025
+0.3%
Avg return
Earnings day
+0.5%
Avg return
5 days after
-1.2%
Avg return
30 days after
52%
26 / 50 earnings
Positive
+14.4%
Q3 2022
Best reaction
-30.2%
Q4 2021
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +11.3% | +9.1% | +3.0% | |
| Q4 2025 | -4.3% | -7.4% | -18.8% | |
| Q3 2025 | -6.5% | +4.2% | +1.7% | |
| Q1 2025 | +5.8% | +2.2% | +1.3% | |
| Q4 2024 | -15.2% | -16.6% | -22.8% | |
| Q3 2024 | +11.6% | +11.4% | +9.6% | |
| Q2 2024 | +3.7% | +1.8% | -0.8% | |
| Q1 2024 | -5.5% | -5.7% | -11.3% | |
| Q4 2023 | -6.5% | -6.6% | -9.8% | |
| Q3 2023 | +0.1% | -0.1% | +6.0% | |
| Q2 2023 | +5.3% | +7.2% | -4.4% | |
| Q1 2023 | +5.0% | +0.0% | +4.6% | |
| Q4 2022 | -1.0% | -3.3% | -17.2% | |
| Q3 2022 | +14.4% | +17.9% | +12.4% | |
| Q2 2022 | +7.5% | +14.4% | -0.1% | |
| Q1 2022 | +5.1% | +11.4% | +19.2% | |
| Q4 2021 | -30.2% | -29.8% | -24.4% | |
| Q3 2021 | +6.1% | +2.8% | -9.5% | |
| Q2 2021 | +6.0% | +4.9% | +2.1% | |
| Q1 2021 | +7.5% | +13.6% | +9.7% | |
| Q4 2018 | -3.8% | -6.3% | -5.9% | |
| Q4 2020 | -3.8% | -18.5% | -23.1% | |
| Q3 2020 | +3.8% | +2.8% | +17.0% | |
| Q2 2020 | -3.0% | -2.3% | -7.9% | |
| Q1 2020 | +4.2% | -3.7% | +4.8% | |
| Q4 2019 | +4.2% | -3.7% | +4.8% | |
| Q3 2019 | +2.5% | -2.0% | +1.6% | |
| Q2 2019 | +2.1% | +3.4% | +9.1% | |
| Q1 2019 | +0.5% | -3.2% | -3.8% | |
| Q3 2018 | -0.3% | -1.6% | -14.8% | |
| Q2 2018 | +0.8% | -1.0% | -0.3% | |
| Q1 2018 | -4.0% | -0.9% | -4.4% | |
| Q4 2017 | +1.9% | +4.7% | +8.7% | |
| Q3 2017 | +5.0% | +22.5% | +24.3% | |
| Q2 2017 | -0.6% | -0.7% | -0.8% | |
| Q1 2017 | -3.4% | -4.1% | -7.4% | |
| Q4 2016 | +4.6% | +6.0% | -1.9% | |
| Q3 2016 | -5.2% | -5.6% | -7.5% | |
| Q2 2016 | +1.0% | +1.5% | +9.3% | |
| Q1 2016 | -1.4% | — | — | |
| Q4 2015 | -2.2% | — | — | |
| Q3 2015 | -1.5% | — | — | |
| Q2 2015 | -1.7% | — | — | |
| Q1 2015 | -3.7% | — | — | |
| Q4 2014 | -2.3% | — | — | |
| Q3 2014 | -1.7% | — | — | |
| Q2 2014 | +0.1% | — | — | |
| Q1 2014 | +0.0% | — | — | |
| Q4 2013 | +1.4% | — | — | |
| Q3 2013 | -0.4% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro